Novel combined single dose anti-hepatitis C therapy: a pilot study

Código QR

Novel combined single dose anti-hepatitis C therapy: a pilot study

Abstract The new anti-hepatitis C virus (HCV) molecules improve treatment regimens and outcomes, but there are drawbacks. New combinations should target the HCV infectious cycle and be effective against all HCV genotypes. We developed the novel formulation Catvira, composed of epigallocatechingallat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gamal Shiha, Reham Soliman, Mohamed Elbasiony, Noureldien H. E. Darwish, Shaker A. Mousa
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/c125c5d7acf641d7bc44530b72c5414f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes JA, et al.
Publicado: (2015)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Yinan Shi, et al.
Publicado: (2021)

PK/PD modeling analysis for dosing regimen selection of isatuximab as single agent and in combination therapy in patients with multiple myeloma
por: Kimiko Koiwai, et al.
Publicado: (2021)

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
por: Xavier Woot de Trixhe, et al.
Publicado: (2021)

Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
por: Ozlem Ozen Karakus, et al.
Publicado: (2021)

Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.
por: Anna-Katharina Böhm, et al.
Publicado: (2021)

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
por: Pascale Lejeune, et al.
Publicado: (2021)

Fractionated photothermal therapy in a murine tumor model: comparison with single dose
por: Simón M, et al.
Publicado: (2019)

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
por: Yang You, et al.
Publicado: (2021)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Takeo Isozaki, et al.
Publicado: (2010)

Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
por: Fang Wei, et al.
Publicado: (2014)

Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults
por: Sasai H, et al.
Publicado: (2017)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
por: Lerner SF, et al.
Publicado: (2019)

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
por: Pol S, et al.
Publicado: (2016)

Vacuna anti hepatitis A
por: COFRÉ G.,JOSÉ, et al.
Publicado: (2003)

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
por: Jean Galtier, et al.
Publicado: (2021)

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity
por: Masashi Arita, et al.
Publicado: (2021)

Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study
por: Okuda T, et al.
Publicado: (2017)

Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
por: Dhruba J Bharali, et al.
Publicado: (2009)

Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in Somalia
por: Mohamed Osman Omar Jeele, et al.
Publicado: (2021)

A Combined Self-Assembled Drug Delivery for Effective Anti-Breast Cancer Therapy
por: Wang H, et al.
Publicado: (2021)

THE OCCURRENCE OF THE MARKERS OF HEPATITIS C AMONG PRACTICALLY HEALTHY RESIDENTS OF THE REPUBLIC OF GUINEA: A PILOT STUDY
por: O. V. Kalinina, et al.
Publicado: (2017)

Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial
por: C. Benini, et al.
Publicado: (2021)

Seroprotection Status of Hepatitis B Vaccine in Children with Type 1 Diabetes Mellitus
por: Dina Elsharkawy, et al.
Publicado: (2021)

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
por: Xin Xie, et al.
Publicado: (2022)

An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
por: Stephen I. Walimbwa, et al.
Publicado: (2021)

Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
por: Jutaek Nam, et al.
Publicado: (2018)

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
por: Sundaram V, et al.
Publicado: (2016)

Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro
por: Anna-Klara Amler, et al.
Publicado: (2021)

Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
por: Alexandre F. Aissa, et al.
Publicado: (2021)

Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
por: Loutfy SA, et al.
Publicado: (2020)

Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
por: Loutfy SA, et al.
Publicado: (2021)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming JW, et al.
Publicado: (2015)

SOFOSBUVIR-VELPATASVIR THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 3
por: Arif Qayyum Khan, et al.
Publicado: (2021)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
por: Irina RUSU, et al.
Publicado: (2020)

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
por: Fabrizio Fabrizi, et al.
Publicado: (2021)

New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection – a pilot study
por: Mitran Madalina Irina, et al.
Publicado: (2021)

Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model
por: Brennan S. Dirk, et al.
Publicado: (2021)

The availability of a functional tumor targeting T-cell repertoire determines the anti-tumor efficiency of combination therapy with anti-CTLA-4 and anti-4-1BB antibodies.
por: Benjamin A H Jensen, et al.
Publicado: (2013)

Screening of Swiss Pig Herds for Hepatitis E Virus: A Pilot Study
por: Julia Lienhard, et al.
Publicado: (2021)